Request for Free Sample

Table of Contents:

1. Introduction

1.1 Market Definition

1.2 Scope (Inclusion and Exclusions)

1.3 Research Assumptions

2. Executive Summary

2.1 Market Overview

2.2 Regional Synopsis

2.3 Competitive Summary

3. Research Methodology

3.1 Top-Down Approach

3.2 Bottom-up Approach

3.3. Data Validation

3.4 Primary Interviews

4. Market Dynamics Impact Analysis

4.1 Market Driving Factors Analysis

4.1.2 Drivers

4.1.2 Restraints

4.1.3 Opportunities

4.1.4 Challenges

4.2 PESTLE Analysis

    1. Porter’s Five Forces Model

5. Statistical Insights and Trends Reporting       

5.1 Incidence and Prevalence of Breast Cancer Requiring Core Needle Biopsy (2023)

5.2 Core Needle Biopsy Device Volume, by Region (2020-2032)

5.3 Adoption of Image-Guided Core Needle Biopsy Techniques (2023-2032)

5.4 Regulatory Approvals and Compliance Trends (2023-2032)

5.5 Healthcare Spending on Breast Cancer Diagnostics, by Region (2023)

6. Competitive Landscape

6.1 List of Major Companies, By Region

6.2 Market Share Analysis, By Region

6.3 Product Benchmarking

6.3.1 Product specifications and features

6.3.2 Pricing

6.4 Strategic Initiatives

6.4.1 Marketing and promotional activities

6.4.2 Distribution and Supply Chain Strategies

6.4.3 Expansion plans and new product launches

6.4.4 Strategic partnerships and collaborations

6.5 Technological Advancements

6.6 Market Positioning and Branding

7. Breast Cancer Core Needle Biopsy Market Segmentation, By Technology

7.1 Chapter Overview

7.2 MRI-Based Breast Biopsy

7.2.1 MRI-Based Breast Biopsy Market Trends Analysis (2020-2032)

7.2.2 MRI-Based Breast Biopsy Market Size Estimates and Forecasts to 2032 (USD Million)

7.3 Ultrasound-Based Breast Biopsy

7.3.1 Ultrasound-Based Breast Biopsy Market Trends Analysis (2020-2032)

7.3.2 Ultrasound-Based Breast Biopsy Market Size Estimates and Forecasts to 2032 (USD Million)

7.4 Mammography-Based (Stereotactic) Breast Biopsy

7.4.1 Mammography-Based (Stereotactic) Breast Biopsy Market Trends Analysis (2020-2032)

7.4.2 Mammography-Based (Stereotactic) Breast Biopsy Market Size Estimates and Forecasts to 2032 (USD Million)

7.5 CT-Based Breast Biopsy

7.5.1 CT-Based Breast Biopsy Market Trends Analysis (2020-2032)

7.5.2 CT-Based Breast Biopsy Market Size Estimates and Forecasts to 2032 (USD Million)

7.6 Other Image-Based Breast Biopsy

7.6.1 Other Image-Based Breast Biopsy Market Trends Analysis (2020-2032)

7.6.2 Other Image-Based Breast Biopsy Market Size Estimates and Forecasts to 2032 (USD Million)

8. Breast Cancer Core Needle Biopsy Market Segmentation, By End User

8.1 Chapter Overview

8.2 Hospitals & Diagnostic Laboratories

8.2.1 Hospitals & Diagnostic Laboratories Market Trends Analysis (2020-2032)

8.2.2 Hospitals & Diagnostic Laboratories Market Size Estimates and Forecasts to 2032 (USD Million)

8.3 Pharmaceutical & Biotechnology companies

8.3.1 Pharmaceutical & Biotechnology Companies Market Trends Analysis (2020-2032)

8.3.2 Pharmaceutical & Biotechnology companies Market Size Estimates and Forecasts to 2032 (USD Million)

8.4 Academic & Research Institutes

8.4.1 Academic & Research Institutes Market Trends Analysis (2020-2032)

8.4.2 Academic & Research Institutes Market Size Estimates and Forecasts to 2032 (USD Million)

9. Regional Analysis

9.1 Chapter Overview

9.2 North America

9.2.1 Trends Analysis

9.2.2 North America Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Country (2020-2032) (USD Million)

9.2.3 North America Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million) 

9.2.4 North America Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.2.5 USA

9.2.5.1 USA Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.2.5.2 USA Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.2.6 Canada

9.2.6.1 Canada Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.2.6.2 Canada Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.2.7 Mexico

9.2.7.1 Mexico Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.2.7.2 Mexico Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.3 Europe

9.3.1 Eastern Europe

9.3.1.1 Trends Analysis

9.3.1.2 Eastern Europe Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Country (2020-2032) (USD Million)

9.3.1.3 Eastern Europe Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million) 

9.3.1.4 Eastern Europe Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.3.1.5 Poland

9.3.1.5.1 Poland Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.3.1.5.2 Poland Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.3.1.6 Romania

9.3.1.6.1 Romania Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.3.1.6.2 Romania Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.3.1.7 Hungary

9.3.1.7.1 Hungary Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.3.1.7.2 Hungary Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.3.1.8 Turkey

9.3.1.8.1 Turkey Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.3.1.8.2 Turkey Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.3.1.9 Rest of Eastern Europe

9.3.1.9.1 Rest of Eastern Europe Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.3.1.9.2 Rest of Eastern Europe Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.3.2 Western Europe

9.3.2.1 Trends Analysis

9.3.2.2 Western Europe Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Country (2020-2032) (USD Million)

9.3.2.3 Western Europe Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million) 

9.3.2.4 Western Europe Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.3.2.5 Germany

9.3.2.5.1 Germany Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.3.2.5.2 Germany Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.3.2.6 France

9.3.2.6.1 France Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.3.2.6.2 France Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.3.2.7 UK

9.3.2.7.1 UK Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.3.2.7.2 UK Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.3.2.8 Italy

9.3.2.8.1 Italy Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.3.2.8.2 Italy Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.3.2.9 Spain

9.3.2.9.1 Spain Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.3.2.9.2 Spain Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.3.2.10 Netherlands

9.3.2.10.1 Netherlands Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.3.2.10.2 Netherlands Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.3.2.11 Switzerland

9.3.2.11.1 Switzerland Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.3.2.11.2 Switzerland Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.3.2.12 Austria

9.3.2.12.1 Austria Healthcare Predictive Analytic Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.3.2.12.2 Austria Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.3.2.13 Rest of Western Europe

9.3.2.13.1 Rest of Western Europe Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.3.2.13.2 Rest of Western Europe Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.4 Asia Pacific

9.4.1 Trends Analysis

9.4.2 Asia Pacific Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Country (2020-2032) (USD Million)

9.4.3 Asia Pacific Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million) 

9.4.4 Asia Pacific Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.4.5 China

9.4.5.1 China Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.4.5.2 China Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.4.6 India

9.4.5.1 India Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.4.5.2 India Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.4.5 Japan

9.4.5.1 Japan Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.4.5.2 Japan Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.4.6 South Korea

9.4.6.1 South Korea Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.4.6.2 South Korea Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.4.7 Vietnam

9.4.7.1 Vietnam Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.2.7.2 Vietnam Healthcare Predictive Analytic Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.4.8 Singapore

9.4.8.1 Singapore Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.4.8.2 Singapore Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.4.9 Australia

9.4.9.1 Australia Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.4.9.2 Australia Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.4.10 Rest of Asia Pacific

9.4.10.1 Rest of Asia Pacific Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.4.10.2 Rest of Asia Pacific Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.5 Middle East and Africa

9.5.1 Middle East

9.5.1.1 Trends Analysis

9.5.1.2 Middle East Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Country (2020-2032) (USD Million)

9.5.1.3 Middle East Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million) 

9.5.1.4 Middle East Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.5.1.5 UAE

9.5.1.5.1 UAE Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.5.1.5.2 UAE Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.5.1.6 Egypt

9.5.1.6.1 Egypt Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.5.1.6.2 Egypt Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.5.1.7 Saudi Arabia

9.5.1.7.1 Saudi Arabia Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.5.1.7.2 Saudi Arabia Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.5.1.8 Qatar

9.5.1.8.1 Qatar Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.5.1.8.2 Qatar Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.5.1.9 Rest of Middle East

9.5.1.9.1 Rest of Middle East Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.5.1.9.2 Rest of Middle East Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.5.2 Africa

9.5.2.1 Trends Analysis

9.5.2.2 Africa Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Country (2020-2032) (USD Million)

9.5.2.3 Africa Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million) 

9.5.2.4 Africa Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.5.2.5 South Africa

9.5.2.5.1 South Africa Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.5.2.5.2 South Africa Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.5.2.6 Nigeria

9.5.2.6.1 Nigeria Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.5.2.6.2 Nigeria Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.5.2.7 Rest of Africa

9.5.2.7.1 Rest of Africa Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.5.2.7.2 Rest of Africa Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.6 Latin America

9.6.1 Trends Analysis

9.6.2 Latin America Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Country (2020-2032) (USD Million)

9.6.3 Latin America Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million) 

9.6.4 Latin America Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.6.5 Brazil

9.6.5.1 Brazil Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.6.5.2 Brazil Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.6.6 Argentina

9.6.6.1 Argentina Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.6.6.2 Argentina Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.6.7 Colombia

9.6.7.1 Colombia Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.6.7.2 Colombia Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

9.6.8 Rest of Latin America

9.6.8.1 Rest of Latin America Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by Technology (2020-2032) (USD Million)

9.6.8.2 Rest of Latin America Breast Cancer Core Needle Biopsy Market Estimates and Forecasts, by End-Use (2020-2032) (USD Million)

10. Company Profiles

10.1 Hologic, Inc.

10.1.1 Company Overview

10.1.2 Financial

10.1.3 Products/ Services Offered

110.1.4 SWOT Analysis

10.2 Becton, Dickinson and Company

             10.2.1 Company Overview

10.2.2 Financial

10.2.3 Products/ Services Offered

10.2.4 SWOT Analysis

10.3 Mammotome

             10.3.1 Company Overview

10.3.2 Financial

10.3.3 Products/ Services Offered

10.3.4 SWOT Analysis

10.4 Resitu Medical

10.4.1 Company Overview

10.4.2 Financial

10.4.3 Products/ Services Offered

10.4.4 SWOT Analysis

10.5 Siemens Healthineers

             10.5.1 Company Overview

10.5.2 Financial

10.5.3 Products/ Services Offered

10.5.4 SWOT Analysis

10.6 Stryker Corporation

             10.6.1 Company Overview

10.6.2 Financial

10.6.3 Products/ Services Offered

10.6.4 SWOT Analysis

10.7 Cook Medical

             10.7.1 Company Overview

10.7.2 Financial

10.7.3 Products/ Services Offered

10.7.4 SWOT Analysis

10.8 Argon Medical Devices, Inc.

10.8.1 Company Overview

10.8.2 Financial

10.8.3 Products/ Services Offered

10.8.4 SWOT Analysis

10.9 B. Braun Melsungen AG

10.9.1 Company Overview

10.9.2 Financial

10.9.3 Products/ Services Offered

10.9.4 SWOT Analysis

10.10 Cardinal Health

             10.9.1 Company Overview

10.9.2 Financial

10.9.3 Products/ Services Offered

10.9.4 SWOT Analysis

11. Use Cases and Best Practices

12. Conclusion